Levetiracetam Tablet, Film Coated
Product Images NDC 82009-124

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 82009-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetamstruct (Levetiracetamstruct)

Chemical structure of levetiracetam, showing its molecular framework including a pyrrolidone ring and side chains with functional groups.*

FDA Label Image

Levetiracetamfigure1 (Levetiracetamfigure1)

Bar graph showing the percentage of patients for placebo and two Levetiracetam dosing groups: 1000 mg/day and 3000 mg/day. Percentages are approximately 7.4% for placebo, 37.1% for Levetiracetam 1000 mg/day, and 39.6% for Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients, while the x-axis labels the treatment groups with their respective sample sizes.*

FDA Label Image

Levetiracetamfigure2 (Levetiracetamfigure2)

A bar chart depicting the percentage of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The x-axis shows the treatment groups with sample sizes, and the y-axis shows the percentage of patients from 0% to 45%.*

FDA Label Image

Levetiracetamfigure3 (Levetiracetamfigure3)

A bar chart comparing the percentage of patients for two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%. The y-axis is labeled '% of Patients' with values from 0% to 45%.*

FDA Label Image

Levetiracetamfigure4 (Levetiracetamfigure4)

A bar chart comparing the percentage of patients between a placebo group (N=97) and a Levetiracetam group (N=101). The placebo bar shows 19.6% of patients, while the Levetiracetam bar shows 44.6% of patients, with the y-axis labeled as '% of Patients' ranging from 0% to 45%.*

FDA Label Image

Levetiracetamfigure5 (Levetiracetamfigure5)

A bar graph comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, ranging from 0% to 45%. The Placebo group shows about 19.6% of patients, while the Levetiracetam group shows about 43.1%, with an asterisk indicating statistical significance or a notable difference.*

FDA Label Image

Levetiracetamfigure6 (Levetiracetamfigure6)

A bar graph comparing the percentage of patients between two groups: Placebo (N=84) and Levetiracetam (N=79). The y-axis represents the percentage of patients ranging from 0% to 100%. The Placebo group shows 45.2% while the Levetiracetam group shows 72.2%, indicating a higher percentage in the Levetiracetam group.*

FDA Label Image

Levetiracetam250mg500s (Levetiracetam250mg500s)

Levetiracetam Tablets USP 250 mg film-coated oral tablets, labeled for 500 tablets per container. The label includes the NDC 82009-121-05 and states the product is manufactured for Quallent Pharmaceuticals Health LLC. Storage instructions and pharmacist dispensing guidance are provided. Manufactured by Hetero Labs Limited, India.*

FDA Label Image

Levetiracetam500mg500s (Levetiracetam500mg500s)

Levetiracetam Tablets, USP 500 mg film-coated tablets, packaged as 500 tablets. The label shows the manufacturer as Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, and manufacturing by Hetero Labs Limited in India. The label includes storage instructions, pharmacist dispensing guidance, and a barcode.*

FDA Label Image

Levetiracetam750mg500s (Levetiracetam750mg500s)

Label for Levetiracetam Tablets USP 750 mg, film-coated oral tablets. The label states a package count of 500 tablets. It includes dispensing instructions, storage conditions, manufacturer details (Hetero Labs Limited, India), and is manufactured for Quallent Pharmaceuticals Health LLC. The label has a barcode and a note on the requirement to provide a medication guide to the patient.*

FDA Label Image

Levetiracetam1000mg60s (Levetiracetam1000mg60s)

Label for Levetiracetam Tablets USP 1000 mg film-coated tablets. The label indicates the product is manufactured for Quallent Pharmaceuticals Health LLC and contains 60 tablets. Storage instructions specify 20 to 25 degrees Celsius. The label includes a barcode and manufacturer information for Hetero Labs Limited in India.*

FDA Label Image

Levetiracetam250mg500sannora (Levetiracetam250mg500sannora)

Levetiracetam Tablets, USP 250 mg film-coated tablets label by Quallent Pharmaceuticals Health LLC. The label includes NDC 82009-121-05, quantity of 500 tablets, storage instructions, pharmacist dispensing guidance, and manufacturing information by Annora Pharma Pvt. Ltd., India. It also features a barcode and a caution for pharmacists regarding the medication guide.*

FDA Label Image

Levetiracetam500mg500sannora (Levetiracetam500mg500sannora)

Levetiracetam Tablets USP 500 mg film-coated tablets label from Quallent Pharmaceuticals Health LLC. The label displays the product name, strength, dosage form, and quantity of 500 tablets. It includes pharmacist instructions, storage conditions, manufacturer information, a barcode, and a warning that each patient must receive the accompanying medication guide.*

FDA Label Image

Levetiracetam750mg500sannora (Levetiracetam750mg500sannora)

Label for Levetiracetam Tablets USP 750 mg film-coated tablets from Quallent Pharmaceuticals Health LLC. The label states the package contains 500 tablets. It includes storage instructions, pharmacist dispensing guidelines, a barcode, manufacturer information (Annora Pharma Pvt. Ltd., India), and a notice about the accompanying medication guide. The label also shows the NDC number 82009-123-05.*

FDA Label Image

Levetiracetam1000mg60sannora (Levetiracetam1000mg60sannora)

Levetiracetam 1000 mg film-coated tablets packaging label by Quallent Pharmaceuticals Health LLC. The label indicates 60 tablets per container and includes storage instructions, pharmacist dispensing guidelines, and manufacturer information. The label features a barcode and a highlighted dosage strength in purple.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.